H79TI085734
Project Grant
Overview
Grant Description
New Mexico State Opioid Response 3 (NMSOR3) - New Mexico is positioned to address the Opioid Use Disorder (OUD) crisis through implementation of evidence-based practices (EBPs) in prevention, treatment, recovery, and harm reduction through use of the SOR 3 funds.
The New Mexico State Opioid Response 3 (NMSOR3) grant will continue to expand capacity to address OUD morbidity and mortality via the modified Hub and Spoke model (Collaborative Hubs model) to support the adoption and implementation of EBPs statewide that have proven effectiveness to prevent, treat, support recovery, and reduce harm related to OUD.
NMSOR3 will support services across a broad range of ages and cultural and ethnic groups, including Native American communities and Hispanic populations. The overarching goal of NMSOR3 is to reduce OUD rates and overdose deaths. To accomplish this, NMSOR3 has the following specific goals:
1. Increase access to Medication-Assisted Treatment (MAT) using three FDA-approved medications for the treatment of OUD.
2. Ensure MAT is comprehensive and includes FDA-approved medications, therapy, and recovery supports.
3. Expand access to recovery services, including peer supports.
4. Expand access to evidence-based prevention activities.
5. Expand tribal-focused Opioid Use Disorder education efforts.
6. Ensure continuous quality improvement through quality data collection, reporting, and evaluation.
We will accomplish these goals by expanding upon the NM Collaborative Hubs approach. Collaborative Hub partners will provide:
- Comprehensive MAT services for persons with OUD.
- Evidence-based prevention services in primary and secondary schools.
- Awareness and engagement in MAT using a statewide media campaign.
- Training in the use of naloxone for harm reduction and engagement of survivors of overdose in MAT (buprenorphine and methadone treatments).
- Training and support to the health care workforce (primary care, behavioral health, recovery), first responders on the use of naloxone to help reverse overdose.
- Training in all components of MAT, including prescribing of FDA-approved medications, psychosocial supports (e.g., motivational interviewing, community reinforcement approach, CRAFT), and recovery supports with a focus on the expansion of peer recovery services.
The GPRA tool will be collected on all individuals receiving treatment and recovery services, with 500 persons reached annually and 1000 persons over the life of the 2-year grant. Prevention numbers served are 50,000 annually (100,000 over the life of the grant).
The New Mexico State Opioid Response 3 (NMSOR3) grant will continue to expand capacity to address OUD morbidity and mortality via the modified Hub and Spoke model (Collaborative Hubs model) to support the adoption and implementation of EBPs statewide that have proven effectiveness to prevent, treat, support recovery, and reduce harm related to OUD.
NMSOR3 will support services across a broad range of ages and cultural and ethnic groups, including Native American communities and Hispanic populations. The overarching goal of NMSOR3 is to reduce OUD rates and overdose deaths. To accomplish this, NMSOR3 has the following specific goals:
1. Increase access to Medication-Assisted Treatment (MAT) using three FDA-approved medications for the treatment of OUD.
2. Ensure MAT is comprehensive and includes FDA-approved medications, therapy, and recovery supports.
3. Expand access to recovery services, including peer supports.
4. Expand access to evidence-based prevention activities.
5. Expand tribal-focused Opioid Use Disorder education efforts.
6. Ensure continuous quality improvement through quality data collection, reporting, and evaluation.
We will accomplish these goals by expanding upon the NM Collaborative Hubs approach. Collaborative Hub partners will provide:
- Comprehensive MAT services for persons with OUD.
- Evidence-based prevention services in primary and secondary schools.
- Awareness and engagement in MAT using a statewide media campaign.
- Training in the use of naloxone for harm reduction and engagement of survivors of overdose in MAT (buprenorphine and methadone treatments).
- Training and support to the health care workforce (primary care, behavioral health, recovery), first responders on the use of naloxone to help reverse overdose.
- Training in all components of MAT, including prescribing of FDA-approved medications, psychosocial supports (e.g., motivational interviewing, community reinforcement approach, CRAFT), and recovery supports with a focus on the expansion of peer recovery services.
The GPRA tool will be collected on all individuals receiving treatment and recovery services, with 500 persons reached annually and 1000 persons over the life of the 2-year grant. Prevention numbers served are 50,000 annually (100,000 over the life of the grant).
Funding Goals
ADDRESSING THE OPIOID ABUSE CRISIS WITHIN SUCH STATES, USED FOR CARRYING OUT ACTIVITIES THAT SUPPLEMENT ACTIVITIES PERTAINING TO OPIOIDS UNDERTAKEN BY THE STATE AGENCY RESPONSIBLE FOR ADMINISTERING THE SUBSTANCE ABUSE PREVENTION AND TREATMENT BLOCK GRANT UNDER SUBPART II OF PART B OF TITLE XIX OF THE PUBLIC HEALTH SERVICE ACT (42 U.S.C. 300X21 ET SEQ.), AND TRIBES AND TRIBAL ORGANIZATIONS TO ADDRESS THE OPIOID CRISIS WITHIN THEIR COMMUNITIES.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Santa Fe,
New Mexico
87507
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been extended from 09/29/24 to 09/29/25 and the total obligations have increased 103% from $7,618,859 to $15,503,826.
New Mexico Department Of Human Services was awarded
NMSOR3: Addressing Opioid Crisis in NM
Project Grant H79TI085734
worth $15,503,826
from the Division of Grants Management in September 2022 with work to be completed primarily in Santa Fe New Mexico United States.
The grant
has a duration of 3 years and
was awarded through assistance program 93.243 Substance Abuse and Mental Health Services Projects of Regional and National Significance.
The Project Grant was awarded through grant opportunity State Opioid Response Grants.
Status
(Ongoing)
Last Modified 1/21/25
Period of Performance
9/30/22
Start Date
9/29/25
End Date
Funding Split
$15.5M
Federal Obligation
$0.0
Non-Federal Obligation
$15.5M
Total Obligated
Activity Timeline
Transaction History
Modifications to H79TI085734
Additional Detail
Award ID FAIN
H79TI085734
SAI Number
H79TI085734-1777551566
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
State Government
Awarding Office
75SAMH SAMHSA DIVISION OF GRANTS MANAGEMENT
Funding Office
75MT00 SAMHSA CENTER FOR SUBSTANCE ABUSE TREATMENT
Awardee UEI
K49NN52HU4L7
Awardee CAGE
3U9U1
Performance District
NM-03
Senators
Martin Heinrich
Ben Luján
Ben Luján
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
Substance Abuse Treatment, Substance Abuse and Mental Health Administration, Health and Human Services (075-1364) | Health care services | Grants, subsidies, and contributions (41.0) | $15,503,826 | 100% |
Modified: 1/21/25